SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-004071
Filing Date
2023-01-17
Accepted
2023-01-17 08:19:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm233557d2_defa14a.htm DEFA14A 28720
2 EXHIBIT 99.1 tm233557d2_ex99-1.htm EX-99.1 29394
3 GRAPHIC tm233557d1_ex99-1img002.jpg GRAPHIC 3372
  Complete submission text file 0001104659-23-004071.txt   64001
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 23530332
SIC: 2834 Pharmaceutical Preparations